The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRsa Ins. 7te%pf Regulatory News (RSAB)

Share Price Information for Rsa Ins. 7te%pf (RSAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 111.50
Bid: 109.50
Ask: 113.50
Change: -0.25 (-0.22%)
Spread: 4.00 (3.653%)
Open: 112.25
High: 111.50
Low: 108.00
Prev. Close: 111.75
RSAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer

28 Sep 2021 12:41

RNS Number : 2470N
RSA Insurance Group Limited
28 September 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (INCLUDING PUERTO RICO, THE US VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS) OR IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (EUWA).

RSA Insurance Group Limited28 September 2021

ANNOUNCEMENT OF ACCEPTANCE AND RESULTS OF RSA INSURANCE GROUP LIMITED'S OFFER TO PURCHASE NOTES FOR CASH

On 20 September 2021, RSA Insurance Group Limited (the "Company") invited holders of its £400,000,000 Fixed Rate Reset Guaranteed Subordinated Notes due 2045 (ISIN: XS1120081283), (the "Notes") to tender their Notes for purchase by or on behalf of the Company for cash, subject to certain offer restrictions as contained in the section "Offer and Distribution Restrictions" of the Tender Offer Memorandum dated 20 September 2021 (the "Tender Offer Memorandum") (the "Offer").

The Expiration Deadline for the Offer was 4.00 p.m. (London time) on 27 September 2021.

As announced in the announcement of indicative results of the Offer earlier today, as at the Expiration Deadline, the Company had received valid tenders for purchase in respect of £341,539,000 in aggregate nominal amount of the Notes. The Company hereby announces the Final Acceptance Amount is £240,000,000 in aggregate nominal amount of the Notes. On the basis of such Final Acceptance Amount, the Company will accept for purchase Notes validly tendered in the Offer subject to pro rata scaling at a Scaling Factor of 70.05725 per cent., as further described in the section "The Offer" of the Tender Offer Memorandum.

Final pricing for the Offer took place at or around 11.00 a.m. (London time) today. The Purchase Price payable by the Company for Notes validly tendered and accepted for purchase will be 114.531 per cent.

A summary of the final pricing for the Offer is set out in the table below:

Benchmark Security Rate

Purchase Spread

Purchase Yield

Purchase Price

0.485 per cent.

90 bps

1.385 per cent. (semi-annual)

1.38980 per cent. (annual)

114.531 per cent.

The Company will also pay an Accrued Interest Payment in respect of Notes accepted for purchase pursuant to the Offer.

The Settlement Date in respect of the Notes accepted for purchase is expected to be 30 September 2021.

Capitalised terms used and not otherwise defined in this announcement have the meanings given in the Tender Offer Memorandum.

DISCLAIMER This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire any securities is being made pursuant to this announcement. The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Company, Royal & Sun Alliance Insurance Limited, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions.

This announcement is released by the Company and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the EUWA (UK MAR), encompassing information relating to the Offer described above. For the purposes of UK MAR and the Implementing Technical Standards, this announcement is made by Jonathan Cope, General Counsel and Company Secretary of the Company.

Company LEI: 549300HOGQ7E0TY86138

For further information, please contact:

 

DEALER MANAGERS

Citigroup Global Markets Limited

HSBC Bank plc

Citigroup CentreCanada SquareCanary WharfLondon E14 5LB

Telephone: +44 (0) 20 7986 8969Attn: Liability Management GroupEmail: liabilitymanagement.europe@citi.com

8 Canada SquareLondon E14 5HQ

 

Telephone: +44 (0)20 7992 6237Attention: Liability ManagementEmail: LM_EMEA@hsbc.com

TENDER AGENT

Lucid Issuer Services LimitedThe Shard32 London Bridge StreetLondon SE1 9SG

Attention: Jacek KusionTelephone: +44 207 704 0880Email: rsa@lucid-is.comWebsite: https://deals.lucid-is.com/rsa

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEUWOARAKUKUAR
Date   Source Headline
21st Mar 20249:53 amRNSAvailability of Guarantor Accounts
6th Mar 20247:00 amRNSDividend Declaration
6th Mar 20247:00 amRNSAnnual Financial Report
26th Oct 20238:45 amRNSApproval of Authority to Allot Shares
4th Aug 20237:00 amRNSDividend Declaration
4th Aug 20237:00 amRNSRSA 2023 Interim Results
2nd Jun 20232:49 pmRNSResult of Tender Offer
24th May 20238:14 amRNSTender Offer
3rd Mar 20237:00 amRNSDividend Declaration
3rd Mar 20237:00 amRNSAnnual Financial Report
3rd Mar 20237:00 amRNSAvailability of Guarantor Accounts
27th Feb 202311:43 amRNSApproval of Authority to Allot Shares
3rd Aug 20227:00 amRNSDividend Declaration
3rd Aug 20227:00 amRNSRSA Insurance Group Limited 2022 Interim Results
25th May 20224:39 pmRNSAvailability of Guarantor Accounts
30th Mar 20222:05 pmRNSAnnual Financial Report
11th Mar 20224:25 pmRNSRSA FY21 Preliminary Results
7th Mar 20221:17 pmRNSNotice of redemption of debt
7th Mar 20221:15 pmRNSNotice of redemption of debt
2nd Mar 20222:00 pmRNSDividend Declaration
23rd Feb 20226:28 pmRNSForm 8.3 - Menzies (John) plc
28th Sep 202112:41 pmRNSResult of Tender Offer
28th Sep 20217:00 amRNSResult of Tender Offer
20th Sep 20219:16 amRNSTender Offer
4th Aug 20218:00 amRNSHalf-year Report
4th Aug 20218:00 amRNSDividend Declaration
9th Mar 20184:40 pmRNSRSAB - Second Price Monitoring Extn
9th Mar 20184:35 pmRNSRSAB - Price Monitoring Extension
27th Aug 201511:55 amRNSForm 8.3 - RSA Insurance Group plc
3rd Aug 201511:55 amRNSForm 8.3 - RSA Insurance Group plc
31st Jul 201511:06 amRNSForm 8.3 - RSA Insurance Group.
29th Jul 201511:55 amRNSForm 8.3 - RSA Insurance Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.